| Similar Articles |
|---|
 |
Chemistry World
August 19, 2008
Ananyo Bhattacharya |
Flask synthesis promises untainted heparin US researchers have created milligrams of pure heparin using enzymes and chemicals - a practical laboratory synthesis that could avoid the contamination issues surrounding the blood-thinning drug   |
Chemistry World
August 11, 2015
Emma Cooper |
Streamlined synthesis yields longer sugar chains By using bigger building blocks, scientists in the UK have shown they can make much longer oligosaccharide sequences than previously possible. |
Chemistry World
April 20, 2011
Jon Cartwright |
New clotting drug antidote could cut surgery risk Chemists in the UK have developed a possible alternative to protamine, a molecule used by doctors to counteract the effects of anti-clotting drugs. |
Chemistry World
August 7, 2015
Suzanne Howson |
Simple probe for heparin quality control Scientists in China have developed a fluorescent probe to detect both heparin and its major contaminant. The sensor could make it easier to monitor the quality of heparin supplies. |
Chemistry World
January 22, 2014
Eleanor Merritt |
Designer esters for complex carbohydrates Scientists based in the US have developed a new strategy to simplify the chemical synthesis of complex carbohydrates. |
Chemistry World
February 12, 2014
Amy Middleton-Gear |
Neutralizing heparin without complications Recovering from operations could become easier thanks to a self-assembling multivalent heparin binding agent being developed by scientists in the UK, Italy and Spain. |
Chemistry World
April 2007
Derek Lowe |
Opinion: In the Pipeline Natural products can be ridiculously complicated. The sheer difficulty of the enterprise is traditionally what made pharmaceutical companies hire people who had worked in total synthesis. But, is total synthesis research still worth the effort? |
American Family Physician
March 15, 2002
Khalid Almoosa |
Is Thrombolytic Therapy Effective for Pulmonary Embolism? No evidence from clinical trials proves that thrombolytic therapy reduces the recurrence rate of pulmonary embolism or affects mortality in hemodynamically stable patients... |
